Fragment-based drug discovery and mechanistic studies of human thymidylate synthase

Human thymidylate synthase (hTS) is the sole enzyme responsible for de novo biosynthesis of dTMP and is vital to cell proliferation and survival. Inhibition of hTS has been explored and found to be effective in cancer chemotherapy, while the efficacy is limited by drug resistance. Herein fragment sc...

Full description

Bibliographic Details
Main Author: Chen, Dan
Other Authors: -
Format: Thesis-Doctor of Philosophy
Language:English
Published: Nanyang Technological University 2016
Subjects:
Online Access:https://hdl.handle.net/10356/65932
_version_ 1826120229243060224
author Chen, Dan
author2 -
author_facet -
Chen, Dan
author_sort Chen, Dan
collection NTU
description Human thymidylate synthase (hTS) is the sole enzyme responsible for de novo biosynthesis of dTMP and is vital to cell proliferation and survival. Inhibition of hTS has been explored and found to be effective in cancer chemotherapy, while the efficacy is limited by drug resistance. Herein fragment screening is applied to hTS to identify novel start point for drug design. Four types of hits are found, of which two are progressed to structure- and biophysics-driven drug design due to novel binding modes in the active site. The elaborated compounds show significant improvements in affinities and open new avenues for development of hTS inhibitors to overcome drug resistance. Meanwhile, another type of hit reveals a potential allosteric site of hTS possibly involved in regulating overexpression-induced drug resistance to hTS inhibitors.
first_indexed 2024-10-01T05:13:06Z
format Thesis-Doctor of Philosophy
id ntu-10356/65932
institution Nanyang Technological University
language English
last_indexed 2024-10-01T05:13:06Z
publishDate 2016
publisher Nanyang Technological University
record_format dspace
spelling ntu-10356/659322023-02-28T18:39:55Z Fragment-based drug discovery and mechanistic studies of human thymidylate synthase Chen, Dan - School of Biological Sciences Nordlund Paer Lennart - DRNTU::Science::Biological sciences::Molecular biology Human thymidylate synthase (hTS) is the sole enzyme responsible for de novo biosynthesis of dTMP and is vital to cell proliferation and survival. Inhibition of hTS has been explored and found to be effective in cancer chemotherapy, while the efficacy is limited by drug resistance. Herein fragment screening is applied to hTS to identify novel start point for drug design. Four types of hits are found, of which two are progressed to structure- and biophysics-driven drug design due to novel binding modes in the active site. The elaborated compounds show significant improvements in affinities and open new avenues for development of hTS inhibitors to overcome drug resistance. Meanwhile, another type of hit reveals a potential allosteric site of hTS possibly involved in regulating overexpression-induced drug resistance to hTS inhibitors. Doctor of Philosophy 2016-01-29T02:53:41Z 2016-01-29T02:53:41Z 2016 Thesis-Doctor of Philosophy https://hdl.handle.net/10356/65932 10.32657/10356/65932 en This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). 176 p. application/pdf Nanyang Technological University
spellingShingle DRNTU::Science::Biological sciences::Molecular biology
Chen, Dan
Fragment-based drug discovery and mechanistic studies of human thymidylate synthase
title Fragment-based drug discovery and mechanistic studies of human thymidylate synthase
title_full Fragment-based drug discovery and mechanistic studies of human thymidylate synthase
title_fullStr Fragment-based drug discovery and mechanistic studies of human thymidylate synthase
title_full_unstemmed Fragment-based drug discovery and mechanistic studies of human thymidylate synthase
title_short Fragment-based drug discovery and mechanistic studies of human thymidylate synthase
title_sort fragment based drug discovery and mechanistic studies of human thymidylate synthase
topic DRNTU::Science::Biological sciences::Molecular biology
url https://hdl.handle.net/10356/65932
work_keys_str_mv AT chendan fragmentbaseddrugdiscoveryandmechanisticstudiesofhumanthymidylatesynthase